news
Ionising radiation found to soften tumour cell microenvironment
When irradiated, less stiff extracellular matrices reduced cancer growth and migration, bolstering the case to further understand fractionated radiation therapy...
List view / Grid view
Anti-Cancer Therapeutics
news
Acoustic Cluster Therapy drives drug therapies to cancer cells
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies...
news
Antibiotics may impact cancer treatment efficacy
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
news
Ponatinib is found to be effective against SCCOHT
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months...
news
Repurposing leukaemia drugs may prevent melanoma metastasis
Data from a new study shows that repurposing drugs used to treat leukaemia has promise for preventing melanoma metastasis...
news
NPL launches Metrology for Medical Physics Centre, MEMPHYS
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
news
Therapeutic gel shows promise against cancerous tumours
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
news
First comparison of common breast cancer tests finds varied accuracy of predictions
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
news
Cancer-fighting nano-robots programmed to seek and destroy tumours
Study shows first applications of DNA origami for nanomedicine...
news
Cancer vaccine eliminates tumours
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
news
New approach identifies existing leukaemia drugs that show promise for Ewing sarcoma treatment
Scientists in the United States have discovered that two existing FDA-approved drugs, clofarabine (Clolar™) and cladribine (Leustatin™), have a powerful inhibitory impact on Ewing sarcoma cells in the lab.
news
FDA approves Lutathera for somatostatin receptor-positive GEP-NETs
The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
news
Combination chemotherapy may significantly improve treatment for glioblastoma
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
news
Cardiff Met develops new cancer treatment
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer...
news
Ogivri approved as the first biosimilar against certain breast and stomach cancers
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
